CLINICAL_TRIALS trial_result · 2021-06-01

Clinical Trial Update: PTI-125 for Mild-to-moderate Alzheimer's Disease Patients [Phase 2]

Phase 2 clinical trial update for PTI-125 in mild-to-moderate Alzheimer's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Cassava Sciences, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-06-01